

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.23385170 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.23385170 |
| 3 | sarcomere organization (GO:0045214) | 9.01927234 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.38130608 |
| 5 | cardiac myofibril assembly (GO:0055003) | 7.96544641 |
| 6 | myofibril assembly (GO:0030239) | 7.75780027 |
| 7 | actin-mediated cell contraction (GO:0070252) | 7.63614111 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 7.62745233 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.37068848 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.07479454 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.81405105 |
| 12 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.73615566 |
| 13 | plasma membrane repair (GO:0001778) | 6.73392111 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.47092467 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.18998763 |
| 16 | tricarboxylic acid cycle (GO:0006099) | 6.08757722 |
| 17 | striated muscle contraction (GO:0006941) | 6.06392168 |
| 18 | cardiac muscle cell development (GO:0055013) | 6.05760685 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.91408403 |
| 20 | actomyosin structure organization (GO:0031032) | 5.87316801 |
| 21 | skeletal muscle contraction (GO:0003009) | 5.74498527 |
| 22 | actin filament-based movement (GO:0030048) | 5.72963168 |
| 23 | cardiac cell development (GO:0055006) | 5.68741198 |
| 24 | regulation of actin filament-based movement (GO:1903115) | 5.65850004 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.59940038 |
| 26 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.56355388 |
| 27 | carnitine shuttle (GO:0006853) | 5.54072293 |
| 28 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.53714449 |
| 29 | regulation of cell communication by electrical coupling (GO:0010649) | 5.48305006 |
| 30 | regulation of sarcomere organization (GO:0060297) | 5.46547660 |
| 31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.44453998 |
| 32 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.24872191 |
| 33 | cardiac muscle hypertrophy (GO:0003300) | 5.17999132 |
| 34 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.15274646 |
| 35 | adult heart development (GO:0007512) | 5.07567326 |
| 36 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.05751877 |
| 37 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.01284557 |
| 38 | striated muscle hypertrophy (GO:0014897) | 5.00297187 |
| 39 | regulation of striated muscle contraction (GO:0006942) | 4.92942156 |
| 40 | skeletal muscle fiber development (GO:0048741) | 4.90234348 |
| 41 | fatty acid transmembrane transport (GO:1902001) | 4.77181939 |
| 42 | heart process (GO:0003015) | 4.74460889 |
| 43 | heart contraction (GO:0060047) | 4.74460889 |
| 44 | muscle tissue morphogenesis (GO:0060415) | 4.73980319 |
| 45 | regulation of membrane repolarization (GO:0060306) | 4.70521854 |
| 46 | heart trabecula formation (GO:0060347) | 4.69066257 |
| 47 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.66293951 |
| 48 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.63464833 |
| 49 | regulation of cofactor metabolic process (GO:0051193) | 4.62204178 |
| 50 | regulation of coenzyme metabolic process (GO:0051196) | 4.62204178 |
| 51 | myotube cell development (GO:0014904) | 4.58731066 |
| 52 | muscle hypertrophy (GO:0014896) | 4.41223019 |
| 53 | skeletal muscle adaptation (GO:0043501) | 4.40577209 |
| 54 | muscle contraction (GO:0006936) | 4.26410888 |
| 55 | creatine metabolic process (GO:0006600) | 4.22293856 |
| 56 | response to inactivity (GO:0014854) | 4.17717002 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.16028755 |
| 58 | cell communication involved in cardiac conduction (GO:0086065) | 4.14792500 |
| 59 | skeletal muscle tissue development (GO:0007519) | 4.12166030 |
| 60 | regulation of the force of heart contraction (GO:0002026) | 4.09425342 |
| 61 | carnitine transmembrane transport (GO:1902603) | 4.06045998 |
| 62 | striated muscle cell development (GO:0055002) | 4.04174684 |
| 63 | striated muscle adaptation (GO:0014888) | 4.03553173 |
| 64 | muscle system process (GO:0003012) | 3.94638488 |
| 65 | negative regulation of potassium ion transport (GO:0043267) | 3.93281170 |
| 66 | muscle cell cellular homeostasis (GO:0046716) | 3.87781070 |
| 67 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.85765479 |
| 68 | muscle hypertrophy in response to stress (GO:0003299) | 3.85765479 |
| 69 | cardiac muscle adaptation (GO:0014887) | 3.85765479 |
| 70 | negative regulation of protein localization to cell surface (GO:2000009) | 3.82606139 |
| 71 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.82127057 |
| 72 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.80486321 |
| 73 | cardiac muscle cell action potential (GO:0086001) | 3.79797659 |
| 74 | glycogen biosynthetic process (GO:0005978) | 3.76709821 |
| 75 | glucan biosynthetic process (GO:0009250) | 3.76709821 |
| 76 | regulation of sulfur metabolic process (GO:0042762) | 3.76589243 |
| 77 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.75843468 |
| 78 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.75829405 |
| 79 | muscle cell fate commitment (GO:0042693) | 3.74527431 |
| 80 | regulation of cardiac muscle contraction (GO:0055117) | 3.72800279 |
| 81 | positive regulation of myotube differentiation (GO:0010831) | 3.71061859 |
| 82 | amino-acid betaine transport (GO:0015838) | 3.68556445 |
| 83 | carnitine transport (GO:0015879) | 3.68556445 |
| 84 | regulation of heart rate (GO:0002027) | 3.67643631 |
| 85 | striated muscle atrophy (GO:0014891) | 3.64341475 |
| 86 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.63798073 |
| 87 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.63798073 |
| 88 | response to muscle activity (GO:0014850) | 3.63219451 |
| 89 | muscle organ development (GO:0007517) | 3.62910163 |
| 90 | muscle structure development (GO:0061061) | 3.62172776 |
| 91 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.60846877 |
| 92 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.59609097 |
| 93 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.59609097 |
| 94 | regulation of ATPase activity (GO:0043462) | 3.59283030 |
| 95 | regulation of ATP catabolic process (GO:1903289) | 3.59283030 |
| 96 | regulation of muscle system process (GO:0090257) | 3.59169465 |
| 97 | cell communication by electrical coupling (GO:0010644) | 3.59104035 |
| 98 | muscle fiber development (GO:0048747) | 3.58864463 |
| 99 | glucan catabolic process (GO:0009251) | 3.58709214 |
| 100 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.56928408 |
| 101 | skeletal muscle tissue regeneration (GO:0043403) | 3.54163357 |
| 102 | glycogen catabolic process (GO:0005980) | 3.53813704 |
| 103 | oxidative phosphorylation (GO:0006119) | 3.53678405 |
| 104 | response to caffeine (GO:0031000) | 3.50561159 |
| 105 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.49922547 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 3.49891143 |
| 107 | NADH metabolic process (GO:0006734) | 3.49257108 |
| 108 | muscle cell development (GO:0055001) | 3.48326200 |
| 109 | ATP synthesis coupled proton transport (GO:0015986) | 3.45655421 |
| 110 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.45655421 |
| 111 | regulation of myoblast differentiation (GO:0045661) | 3.45052163 |
| 112 | relaxation of cardiac muscle (GO:0055119) | 3.43982358 |
| 113 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.41992348 |
| 114 | respiratory electron transport chain (GO:0022904) | 3.38549502 |
| 115 | muscle atrophy (GO:0014889) | 3.37028581 |
| 116 | positive regulation of myoblast differentiation (GO:0045663) | 3.36813460 |
| 117 | muscle adaptation (GO:0043500) | 3.36022858 |
| 118 | regulation of muscle contraction (GO:0006937) | 3.35841339 |
| 119 | regulation of sequestering of triglyceride (GO:0010889) | 3.35488619 |
| 120 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.34810161 |
| 121 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.34756197 |
| 122 | cellular polysaccharide catabolic process (GO:0044247) | 3.34749321 |
| 123 | regulation of heart contraction (GO:0008016) | 3.29972385 |
| 124 | positive regulation of cation channel activity (GO:2001259) | 3.29971703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.53090950 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.81212279 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.37422977 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.23558594 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.23558594 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.03060685 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.67926729 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.61586703 |
| 9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.48620370 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.44049288 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.38098809 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.29151150 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.78153206 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.68859691 |
| 15 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.45138831 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.34681621 |
| 17 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.22182266 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.17739479 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13926457 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.93511134 |
| 21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.91711492 |
| 22 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.89421250 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85513828 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84135747 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78640421 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68741884 |
| 27 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.67477712 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56116335 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52749059 |
| 30 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.47244798 |
| 31 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.44078039 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43010801 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40513163 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38885633 |
| 35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.38715914 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38153206 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35257871 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33672891 |
| 39 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31385170 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30852603 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30691092 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.29871472 |
| 43 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26351291 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23392300 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23065562 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22464533 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22283886 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21760573 |
| 49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.21276957 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.19991670 |
| 51 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.19909321 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17064010 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16150685 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13986422 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12925613 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.11386289 |
| 57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10559379 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09955823 |
| 59 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09799981 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09769872 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09377665 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08462166 |
| 63 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07743181 |
| 64 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06947061 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06926125 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.05417735 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.05417735 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04906751 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04610932 |
| 70 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04602833 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04320345 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03869136 |
| 73 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02977296 |
| 74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01327677 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00300145 |
| 76 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.99912245 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99578118 |
| 78 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99412646 |
| 79 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99227564 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98625728 |
| 81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98620173 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97790243 |
| 83 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97424445 |
| 84 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96682173 |
| 85 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.94172487 |
| 86 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93537100 |
| 87 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93001738 |
| 88 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.92311783 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91648674 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90449619 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90370021 |
| 92 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90274021 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89826037 |
| 94 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89042819 |
| 95 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.88701886 |
| 96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88118882 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87901567 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87742957 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87738741 |
| 100 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.87688472 |
| 101 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.87563633 |
| 102 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86936116 |
| 103 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86744008 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86270993 |
| 105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86262255 |
| 106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86240102 |
| 107 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85740048 |
| 108 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.84979930 |
| 109 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84878290 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84189361 |
| 111 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83811446 |
| 112 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83721099 |
| 113 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.83694721 |
| 114 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83435517 |
| 115 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83418932 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83279919 |
| 117 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82505200 |
| 118 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.81995537 |
| 119 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81781681 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81781681 |
| 121 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.81536384 |
| 122 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.80969122 |
| 123 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79789841 |
| 124 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79379529 |
| 125 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78712423 |
| 126 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78682401 |
| 127 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78478510 |
| 128 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78463408 |
| 129 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.78167999 |
| 130 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77913384 |
| 131 | * P68_20966046_ChIP-Seq_HELA_Human | 0.77460972 |
| 132 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77296687 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77015288 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76681478 |
| 135 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.76544492 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76164080 |
| 137 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.75627777 |
| 138 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75527905 |
| 139 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.74698087 |
| 140 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.74322132 |
| 141 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.74256796 |
| 142 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.74224687 |
| 143 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73734464 |
| 144 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.73110468 |
| 145 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.72936064 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72523816 |
| 147 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.72467435 |
| 148 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.72451125 |
| 149 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.72436732 |
| 150 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.71662850 |
| 151 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.71476061 |
| 152 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.69095495 |
| 153 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.68986485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.16978356 |
| 2 | MP0003646_muscle_fatigue | 5.64764760 |
| 3 | MP0000751_myopathy | 5.56810663 |
| 4 | MP0000749_muscle_degeneration | 4.82811079 |
| 5 | * MP0004084_abnormal_cardiac_muscle | 4.72054382 |
| 6 | MP0004215_abnormal_myocardial_fiber | 4.33220717 |
| 7 | * MP0004036_abnormal_muscle_relaxation | 4.15306664 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.98104987 |
| 9 | MP0005330_cardiomyopathy | 3.76041186 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.39138701 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.16488455 |
| 12 | * MP0002106_abnormal_muscle_physiology | 3.10798626 |
| 13 | * MP0005620_abnormal_muscle_contractility | 2.97565200 |
| 14 | * MP0002972_abnormal_cardiac_muscle | 2.86416631 |
| 15 | MP0004130_abnormal_muscle_cell | 2.79693326 |
| 16 | MP0000747_muscle_weakness | 2.79205878 |
| 17 | MP0002269_muscular_atrophy | 2.77071432 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.63819442 |
| 19 | MP0003137_abnormal_impulse_conducting | 2.61364937 |
| 20 | MP0000759_abnormal_skeletal_muscle | 2.59821389 |
| 21 | * MP0005369_muscle_phenotype | 2.52359215 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.52083235 |
| 23 | MP0004484_altered_response_of | 2.35814755 |
| 24 | * MP0001544_abnormal_cardiovascular_syste | 2.27404864 |
| 25 | * MP0005385_cardiovascular_system_phenoty | 2.27404864 |
| 26 | MP0004233_abnormal_muscle_weight | 2.12730048 |
| 27 | MP0006138_congestive_heart_failure | 2.09441609 |
| 28 | MP0003828_pulmonary_edema | 1.99123188 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.91421730 |
| 30 | MP0004085_abnormal_heartbeat | 1.81429473 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.75807105 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.72961044 |
| 33 | MP0004510_myositis | 1.67184319 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.62401086 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.57685573 |
| 36 | MP0000733_abnormal_muscle_development | 1.38674491 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 1.36238776 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.35523682 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.23459273 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.13436842 |
| 41 | MP0000266_abnormal_heart_morphology | 1.12208035 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.10801252 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.05448140 |
| 44 | MP0000343_altered_response_to | 1.00654682 |
| 45 | MP0001661_extended_life_span | 0.99011625 |
| 46 | MP0005375_adipose_tissue_phenotype | 0.94742699 |
| 47 | MP0005670_abnormal_white_adipose | 0.90481334 |
| 48 | MP0003279_aneurysm | 0.88763129 |
| 49 | MP0005266_abnormal_metabolism | 0.87064791 |
| 50 | MP0005165_increased_susceptibility_to | 0.84835117 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 0.84457520 |
| 52 | MP0010368_abnormal_lymphatic_system | 0.80790253 |
| 53 | MP0002971_abnormal_brown_adipose | 0.80236766 |
| 54 | MP0002128_abnormal_blood_circulation | 0.72603692 |
| 55 | MP0005623_abnormal_meninges_morphology | 0.72000053 |
| 56 | MP0003566_abnormal_cell_adhesion | 0.68092444 |
| 57 | MP0005275_abnormal_skin_tensile | 0.67910147 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.66393866 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.61518376 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 0.61430504 |
| 61 | MP0004272_abnormal_basement_membrane | 0.61109514 |
| 62 | MP0002822_catalepsy | 0.61059182 |
| 63 | MP0000003_abnormal_adipose_tissue | 0.60153057 |
| 64 | MP0005451_abnormal_body_composition | 0.59400889 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 0.56973272 |
| 66 | MP0000767_abnormal_smooth_muscle | 0.52660379 |
| 67 | MP0000372_irregular_coat_pigmentation | 0.49334556 |
| 68 | MP0004043_abnormal_pH_regulation | 0.49173821 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 0.48556877 |
| 70 | MP0004147_increased_porphyrin_level | 0.46578424 |
| 71 | MP0002925_abnormal_cardiovascular_devel | 0.45978780 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.45722006 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.44997299 |
| 74 | MP0008961_abnormal_basal_metabolism | 0.44831579 |
| 75 | MP0005187_abnormal_penis_morphology | 0.42910643 |
| 76 | MP0008569_lethality_at_weaning | 0.41678784 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.39016698 |
| 78 | MP0001784_abnormal_fluid_regulation | 0.38108838 |
| 79 | MP0003984_embryonic_growth_retardation | 0.37609449 |
| 80 | MP0002088_abnormal_embryonic_growth/wei | 0.37030985 |
| 81 | MP0004134_abnormal_chest_morphology | 0.36497351 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.35987598 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.35709065 |
| 84 | MP0003948_abnormal_gas_homeostasis | 0.35325100 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.35226118 |
| 86 | MP0003879_abnormal_hair_cell | 0.34742253 |
| 87 | MP0001614_abnormal_blood_vessel | 0.34398936 |
| 88 | MP0010030_abnormal_orbit_morphology | 0.31962376 |
| 89 | MP0006276_abnormal_autonomic_nervous | 0.31695952 |
| 90 | MP0005334_abnormal_fat_pad | 0.29078834 |
| 91 | MP0004142_abnormal_muscle_tone | 0.28126765 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.27924403 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.27296912 |
| 94 | MP0001984_abnormal_olfaction | 0.27237593 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 0.24815115 |
| 96 | MP0002114_abnormal_axial_skeleton | 0.24690870 |
| 97 | MP0003045_fibrosis | 0.24514594 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.24366987 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.24066624 |
| 100 | MP0009115_abnormal_fat_cell | 0.23717451 |
| 101 | MP0005452_abnormal_adipose_tissue | 0.23414927 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.23195714 |
| 103 | MP0005423_abnormal_somatic_nervous | 0.22673932 |
| 104 | MP0009672_abnormal_birth_weight | 0.21631805 |
| 105 | MP0005535_abnormal_body_temperature | 0.21588700 |
| 106 | MP0001943_abnormal_respiration | 0.21546207 |
| 107 | MP0003941_abnormal_skin_development | 0.21454022 |
| 108 | MP0005503_abnormal_tendon_morphology | 0.20609979 |
| 109 | MP0004924_abnormal_behavior | 0.20080258 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.20080258 |
| 111 | MP0002249_abnormal_larynx_morphology | 0.18687977 |
| 112 | MP0001672_abnormal_embryogenesis/_devel | 0.18505975 |
| 113 | MP0005380_embryogenesis_phenotype | 0.18505975 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.18335459 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.18258196 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.17998886 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.17595433 |
| 118 | MP0000762_abnormal_tongue_morphology | 0.17435447 |
| 119 | MP0004270_analgesia | 0.16594550 |
| 120 | MP0000579_abnormal_nail_morphology | 0.15988095 |
| 121 | MP0004197_abnormal_fetal_growth/weight/ | 0.15762463 |
| 122 | MP0003385_abnormal_body_wall | 0.15362419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.15878762 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.11916834 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 6.90932691 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.65345783 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.50172000 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.98099956 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 5.74613095 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.67934963 |
| 9 | Ventricular tachycardia (HP:0004756) | 5.63709580 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 5.44552110 |
| 11 | Subaortic stenosis (HP:0001682) | 5.24248962 |
| 12 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.24248962 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 5.22674525 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 5.17126650 |
| 15 | Myoglobinuria (HP:0002913) | 5.11639425 |
| 16 | Nemaline bodies (HP:0003798) | 5.03035040 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.71906980 |
| 18 | Atrial fibrillation (HP:0005110) | 4.68535362 |
| 19 | Difficulty running (HP:0009046) | 4.43650803 |
| 20 | Lipoatrophy (HP:0100578) | 4.43618196 |
| 21 | Increased connective tissue (HP:0009025) | 4.39353237 |
| 22 | Primary atrial arrhythmia (HP:0001692) | 4.38149865 |
| 23 | Supraventricular tachycardia (HP:0004755) | 4.23205037 |
| 24 | Supraventricular arrhythmia (HP:0005115) | 4.15396959 |
| 25 | Distal arthrogryposis (HP:0005684) | 4.14199799 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 4.12758827 |
| 27 | Rhabdomyolysis (HP:0003201) | 4.06100962 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 4.01017987 |
| 29 | Syncope (HP:0001279) | 3.85984837 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.76746727 |
| 31 | Myotonia (HP:0002486) | 3.76009854 |
| 32 | Bundle branch block (HP:0011710) | 3.63287590 |
| 33 | Prolonged QT interval (HP:0001657) | 3.56622097 |
| 34 | Palpitations (HP:0001962) | 3.51634886 |
| 35 | Round ear (HP:0100830) | 3.47914985 |
| 36 | Ventricular arrhythmia (HP:0004308) | 3.47855946 |
| 37 | Difficulty climbing stairs (HP:0003551) | 3.37791030 |
| 38 | Myopathic facies (HP:0002058) | 3.31886987 |
| 39 | Muscle stiffness (HP:0003552) | 3.29656246 |
| 40 | Neck muscle weakness (HP:0000467) | 3.18114652 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.13151168 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 3.04869449 |
| 43 | Fetal akinesia sequence (HP:0001989) | 3.04869411 |
| 44 | Heart block (HP:0012722) | 3.03116902 |
| 45 | Ventricular fibrillation (HP:0001663) | 2.95667735 |
| 46 | Ulnar deviation of the wrist (HP:0003049) | 2.95461271 |
| 47 | Abnormal atrioventricular conduction (HP:0005150) | 2.86994089 |
| 48 | Atrioventricular block (HP:0001678) | 2.85152277 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.72883524 |
| 50 | Rimmed vacuoles (HP:0003805) | 2.70368454 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.59628140 |
| 52 | Abnormal EKG (HP:0003115) | 2.56126460 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.52932917 |
| 54 | EMG: neuropathic changes (HP:0003445) | 2.52050304 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.47394596 |
| 56 | Left ventricular hypertrophy (HP:0001712) | 2.44245669 |
| 57 | Calcaneovalgus deformity (HP:0001848) | 2.40737599 |
| 58 | Abnormality of the calcaneus (HP:0008364) | 2.38332779 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.36787631 |
| 60 | Gowers sign (HP:0003391) | 2.35677410 |
| 61 | Popliteal pterygium (HP:0009756) | 2.34374383 |
| 62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.33958348 |
| 63 | Limb-girdle muscle atrophy (HP:0003797) | 2.33743523 |
| 64 | Frequent falls (HP:0002359) | 2.25059032 |
| 65 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.23979224 |
| 66 | Scapular winging (HP:0003691) | 2.23656958 |
| 67 | Absent phalangeal crease (HP:0006109) | 2.22168378 |
| 68 | Hepatic necrosis (HP:0002605) | 2.18293199 |
| 69 | Deformed tarsal bones (HP:0008119) | 2.16496826 |
| 70 | Palmoplantar keratoderma (HP:0000982) | 2.16164482 |
| 71 | Acute necrotizing encephalopathy (HP:0006965) | 2.15755688 |
| 72 | Muscular dystrophy (HP:0003560) | 2.15409819 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.13043884 |
| 74 | Malignant hyperthermia (HP:0002047) | 2.10509440 |
| 75 | Facial diplegia (HP:0001349) | 2.07677762 |
| 76 | Ketoacidosis (HP:0001993) | 2.07191342 |
| 77 | Abnormality of the ischium (HP:0003174) | 2.05376426 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 2.04438973 |
| 79 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.01315412 |
| 80 | Slender build (HP:0001533) | 1.98285559 |
| 81 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96833251 |
| 82 | Conjunctival hamartoma (HP:0100780) | 1.95966990 |
| 83 | Abnormality of the foot musculature (HP:0001436) | 1.94340308 |
| 84 | Hyperkalemia (HP:0002153) | 1.94136208 |
| 85 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.94064162 |
| 86 | Fatigable weakness (HP:0003473) | 1.94016382 |
| 87 | Abnormality of the neuromuscular junction (HP:0003398) | 1.94016382 |
| 88 | Progressive muscle weakness (HP:0003323) | 1.93770588 |
| 89 | Waddling gait (HP:0002515) | 1.93524165 |
| 90 | Proximal amyotrophy (HP:0007126) | 1.93440902 |
| 91 | Hypoglycemic coma (HP:0001325) | 1.92295224 |
| 92 | Type 2 muscle fiber atrophy (HP:0003554) | 1.91854034 |
| 93 | Lower limb amyotrophy (HP:0007210) | 1.89070685 |
| 94 | Spinal rigidity (HP:0003306) | 1.88490093 |
| 95 | Exercise intolerance (HP:0003546) | 1.87329533 |
| 96 | Hepatocellular necrosis (HP:0001404) | 1.86291748 |
| 97 | Bulbar palsy (HP:0001283) | 1.85202962 |
| 98 | Limb-girdle muscle weakness (HP:0003325) | 1.84879423 |
| 99 | Hip contracture (HP:0003273) | 1.84012541 |
| 100 | Increased muscle lipid content (HP:0009058) | 1.83664675 |
| 101 | Metatarsus adductus (HP:0001840) | 1.83108250 |
| 102 | Acute encephalopathy (HP:0006846) | 1.82679879 |
| 103 | Weak cry (HP:0001612) | 1.80507608 |
| 104 | Foot dorsiflexor weakness (HP:0009027) | 1.80438208 |
| 105 | Testicular atrophy (HP:0000029) | 1.79891965 |
| 106 | Aplasia of the musculature (HP:0100854) | 1.79590806 |
| 107 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79083247 |
| 108 | Abnormality of alanine metabolism (HP:0010916) | 1.79083247 |
| 109 | Hyperalaninemia (HP:0003348) | 1.79083247 |
| 110 | Abnormal finger flexion creases (HP:0006143) | 1.78061491 |
| 111 | Progressive macrocephaly (HP:0004481) | 1.77948359 |
| 112 | Sudden cardiac death (HP:0001645) | 1.76499870 |
| 113 | Muscle fiber atrophy (HP:0100295) | 1.72605616 |
| 114 | Limited hip movement (HP:0008800) | 1.66410130 |
| 115 | Amniotic constriction ring (HP:0009775) | 1.65261694 |
| 116 | Abnormality of placental membranes (HP:0011409) | 1.65261694 |
| 117 | Steppage gait (HP:0003376) | 1.64752006 |
| 118 | Long clavicles (HP:0000890) | 1.61182751 |
| 119 | Increased intramyocellular lipid droplets (HP:0012240) | 1.55237952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.43133084 |
| 2 | TTN | 5.89043263 |
| 3 | PHKG1 | 4.54638970 |
| 4 | PHKG2 | 4.54638970 |
| 5 | PDK4 | 3.33883506 |
| 6 | PDK3 | 3.33883506 |
| 7 | PKN2 | 3.01515119 |
| 8 | DMPK | 2.94046025 |
| 9 | TRIB3 | 2.82293599 |
| 10 | LMTK2 | 2.69713400 |
| 11 | NEK1 | 2.68307317 |
| 12 | MYLK | 2.62525602 |
| 13 | STK24 | 2.25907858 |
| 14 | MUSK | 2.22603857 |
| 15 | PIK3CA | 2.14522774 |
| 16 | PDK2 | 2.01524107 |
| 17 | BCKDK | 1.90954631 |
| 18 | PINK1 | 1.82918822 |
| 19 | TIE1 | 1.73090315 |
| 20 | PIK3CG | 1.52381776 |
| 21 | MAP3K7 | 1.48257299 |
| 22 | MARK1 | 1.42817292 |
| 23 | NME1 | 1.40239631 |
| 24 | MAP2K3 | 1.38079495 |
| 25 | ILK | 1.30202343 |
| 26 | MAPK12 | 1.24569972 |
| 27 | GRK7 | 1.22571100 |
| 28 | ZAK | 1.05253480 |
| 29 | PRKD1 | 0.97637536 |
| 30 | CAMK2D | 0.94752780 |
| 31 | CCNB1 | 0.92299372 |
| 32 | PAK3 | 0.91424016 |
| 33 | PRKAA1 | 0.91231732 |
| 34 | TRPM7 | 0.90420709 |
| 35 | MAPKAPK3 | 0.90310611 |
| 36 | ROCK1 | 0.87697256 |
| 37 | PRKAA2 | 0.87488106 |
| 38 | MOS | 0.86789326 |
| 39 | RIPK1 | 0.79285616 |
| 40 | MAP3K5 | 0.78821031 |
| 41 | FLT3 | 0.78414202 |
| 42 | CDC42BPA | 0.78374478 |
| 43 | STK38L | 0.75539583 |
| 44 | INSRR | 0.73085005 |
| 45 | MAP3K3 | 0.68028065 |
| 46 | STK4 | 0.65224345 |
| 47 | NEK9 | 0.64457387 |
| 48 | ERBB3 | 0.62777354 |
| 49 | PDGFRA | 0.62530294 |
| 50 | MAPK4 | 0.58587799 |
| 51 | WNK4 | 0.57428158 |
| 52 | CAMK4 | 0.54396600 |
| 53 | EPHA3 | 0.53468694 |
| 54 | AKT2 | 0.53274198 |
| 55 | DYRK1B | 0.52179858 |
| 56 | CAMK2B | 0.51758412 |
| 57 | PKN1 | 0.51736600 |
| 58 | DAPK3 | 0.50813835 |
| 59 | ROCK2 | 0.49396955 |
| 60 | EPHB1 | 0.49339895 |
| 61 | SIK1 | 0.48719174 |
| 62 | MAP2K4 | 0.47643047 |
| 63 | PTK6 | 0.47079989 |
| 64 | STK38 | 0.45528328 |
| 65 | PRKACB | 0.45428526 |
| 66 | TGFBR2 | 0.44828502 |
| 67 | MAP3K10 | 0.43710838 |
| 68 | CAMK2A | 0.42691099 |
| 69 | LATS1 | 0.41935419 |
| 70 | WNK1 | 0.41354014 |
| 71 | KSR2 | 0.38897612 |
| 72 | ICK | 0.38512120 |
| 73 | PTK2B | 0.38389439 |
| 74 | CAMK2G | 0.37640193 |
| 75 | MAP2K6 | 0.36103006 |
| 76 | MAP3K6 | 0.35677949 |
| 77 | KDR | 0.34007271 |
| 78 | CAMK1 | 0.33852737 |
| 79 | PRKACA | 0.33147097 |
| 80 | RPS6KC1 | 0.32005407 |
| 81 | RPS6KL1 | 0.32005407 |
| 82 | PDPK1 | 0.31194118 |
| 83 | MAPK11 | 0.29907177 |
| 84 | PRKACG | 0.29773679 |
| 85 | LIMK1 | 0.29407712 |
| 86 | LATS2 | 0.28784282 |
| 87 | PDK1 | 0.28293838 |
| 88 | MAP3K13 | 0.27320245 |
| 89 | SGK2 | 0.27291742 |
| 90 | MTOR | 0.26525745 |
| 91 | RPS6KA6 | 0.24768783 |
| 92 | MAPK13 | 0.22968463 |
| 93 | RPS6KA1 | 0.22839271 |
| 94 | PRKG1 | 0.22305199 |
| 95 | MAPK10 | 0.21485483 |
| 96 | STK39 | 0.21442650 |
| 97 | RET | 0.20325257 |
| 98 | RPS6KA3 | 0.19110065 |
| 99 | STK11 | 0.18081509 |
| 100 | SGK1 | 0.17879682 |
| 101 | NLK | 0.17508165 |
| 102 | PRKCE | 0.17450870 |
| 103 | LRRK2 | 0.16764166 |
| 104 | MAPK7 | 0.16452976 |
| 105 | EEF2K | 0.15653495 |
| 106 | RPS6KB2 | 0.14811272 |
| 107 | MARK2 | 0.13761109 |
| 108 | RPS6KB1 | 0.13626522 |
| 109 | FER | 0.13237481 |
| 110 | SGK494 | 0.12371426 |
| 111 | SGK223 | 0.12371426 |
| 112 | TBK1 | 0.12235745 |
| 113 | SGK3 | 0.11705880 |
| 114 | DAPK2 | 0.11649078 |
| 115 | PRKCH | 0.10473849 |
| 116 | MAP2K1 | 0.10409717 |
| 117 | EPHB2 | 0.10356400 |
| 118 | FGFR1 | 0.10263180 |
| 119 | TAOK1 | 0.10204875 |
| 120 | ZAP70 | 0.09885414 |
| 121 | MAP3K11 | 0.09527547 |
| 122 | MAP3K1 | 0.09255620 |
| 123 | PAK6 | 0.08382304 |
| 124 | KSR1 | 0.08183920 |
| 125 | PRKD3 | 0.08038616 |
| 126 | TAOK2 | 0.06921081 |
| 127 | DDR2 | 0.06439260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.89680003 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.35736152 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.24870609 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.11184810 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.02458738 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.03095143 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.01737924 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96895849 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.78486207 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64835793 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.56096698 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.46262093 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.09920861 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.04556524 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97149769 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.94285543 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.92098288 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.85160886 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70288875 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67324600 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.43764308 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38568955 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.36248384 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36037564 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.34190600 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23148429 |
| 27 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.23021240 |
| 28 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16187827 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.13348955 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08362392 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01490416 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00931644 |
| 33 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96031130 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.96001960 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95006141 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 0.93354014 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 0.87911961 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86766676 |
| 39 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79567894 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77961711 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72376948 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72364587 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71521032 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69225418 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 0.68172802 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66752948 |
| 47 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66280064 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60674065 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 0.59686515 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59484131 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57095891 |
| 52 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57079027 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56211598 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55968410 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55752857 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 0.53546668 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52423298 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52368151 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52014121 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.50227141 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49746832 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49534150 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47607587 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46252837 |
| 65 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40364182 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.40147574 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.38392487 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37770365 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37454442 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35785187 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35513214 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35209851 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34294186 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32047889 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31814001 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30653515 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30514898 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29795774 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.28558208 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26788657 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.26139870 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.25864387 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25684672 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.24971839 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24900810 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24663907 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22849050 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22788124 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.21737822 |
| 90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.21368249 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18732281 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.16364696 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15398628 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15032204 |
| 95 | Long-term depression_Homo sapiens_hsa04730 | 0.14694076 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13991623 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.13734850 |
| 98 | GABAergic synapse_Homo sapiens_hsa04727 | 0.13476543 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13302344 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13266054 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12536952 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11201932 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.09934523 |
| 104 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09406159 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09290147 |
| 106 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.09139054 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.09041210 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08362405 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.08136373 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07412044 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06378653 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.05891204 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05140866 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.03240931 |
| 115 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.02288308 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01972070 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.00696586 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.00519327 |

